1. Home
  2. KMDA vs SNBR Comparison

KMDA vs SNBR Comparison

Compare KMDA & SNBR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KMDA
  • SNBR
  • Stock Information
  • Founded
  • KMDA 1990
  • SNBR 1987
  • Country
  • KMDA Israel
  • SNBR United States
  • Employees
  • KMDA N/A
  • SNBR N/A
  • Industry
  • KMDA Biotechnology: Pharmaceutical Preparations
  • SNBR Home Furnishings
  • Sector
  • KMDA Health Care
  • SNBR Consumer Discretionary
  • Exchange
  • KMDA Nasdaq
  • SNBR Nasdaq
  • Market Cap
  • KMDA 442.1M
  • SNBR 399.8M
  • IPO Year
  • KMDA N/A
  • SNBR 1998
  • Fundamental
  • Price
  • KMDA $7.46
  • SNBR $14.49
  • Analyst Decision
  • KMDA Strong Buy
  • SNBR Hold
  • Analyst Count
  • KMDA 2
  • SNBR 3
  • Target Price
  • KMDA $14.50
  • SNBR $12.83
  • AVG Volume (30 Days)
  • KMDA 346.0K
  • SNBR 275.6K
  • Earning Date
  • KMDA 03-05-2025
  • SNBR 03-05-2025
  • Dividend Yield
  • KMDA N/A
  • SNBR N/A
  • EPS Growth
  • KMDA 124.29
  • SNBR N/A
  • EPS
  • KMDA 0.27
  • SNBR N/A
  • Revenue
  • KMDA $158,380,000.00
  • SNBR $1,734,997,000.00
  • Revenue This Year
  • KMDA $15.37
  • SNBR N/A
  • Revenue Next Year
  • KMDA $8.58
  • SNBR $1.68
  • P/E Ratio
  • KMDA $28.13
  • SNBR N/A
  • Revenue Growth
  • KMDA 4.52
  • SNBR N/A
  • 52 Week Low
  • KMDA $4.74
  • SNBR $8.13
  • 52 Week High
  • KMDA $9.15
  • SNBR $20.75
  • Technical
  • Relative Strength Index (RSI)
  • KMDA 52.89
  • SNBR 37.21
  • Support Level
  • KMDA $7.51
  • SNBR $15.81
  • Resistance Level
  • KMDA $8.35
  • SNBR $18.67
  • Average True Range (ATR)
  • KMDA 0.41
  • SNBR 1.18
  • MACD
  • KMDA -0.02
  • SNBR -0.33
  • Stochastic Oscillator
  • KMDA 33.20
  • SNBR 12.73

About KMDA Kamada Ltd.

Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, Proprietary Products segment and Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.

About SNBR Sleep Number Corporation

Sleep Number Corp. is a wellness technology company engaged in the design, manufacturing, marketing and distribution of sleep solutions. The Company generates revenue by marketing and selling its smart beds directly to new and existing customers through its vertically integrated, exclusive, direct-to-consumer retail touch points including Stores, Online, Phone, and Chat (Total Retail). The products offered by the company are Mattresses, Bedding, Pillows and Furniture.

Share on Social Networks: